Search – Page 9 – Indianapolis Business Journal

Home » Search

Articles

UPDATE: City reaches settlement with AES Indiana over proposed rate hike

October 16, 2025 | IBJ Staff

The Indiana Office of Utility Consumer Counselor, which acts on behalf of utility customers, did not join the settlement. Neither did ratepayer advocacy group Citizen’s Action Coalition.

Roche receives FDA clearance for Alzheimer’s blood test

October 15, 2025 | Daniel Lee

The test—developed in collaboration with Eli Lilly and Co.—does not diagnose Alzheimer’s but is designed to rule out the presence of the disease’s pathology early on, or indicate further diagnostics are needed.

Lilly to spend more than $1B to expand operations in India

October 6, 2025 | IBJ Staff

Indianapolis-based Eli Lilly and Co. said the investment will strengthen its manufacturing and supply capabilities to support its growing portfolio of drugs.

Q&A with Elanco’s Jeff Simmons on blockbusters, challenges and growing up on a vineyard

October 3, 2025 | Daniel Lee

Elanco opened the doors of its new headquarters at the former GM stamping plant site this week.

Mitch Frazier: Elanco betting big and moving boldly

October 3, 2025 | Mitch Frazier

The Elanco headquarters is the cornerstone for creating the epicenter of innovation CEO Jeff Simmons envisioned years ago and builds on a series of moves the company has made since it began its headquarters project.

Elanco opens ‘doors to the future’ with new $200M-plus Indianapolis headquarters

October 1, 2025 | Daniel Lee

At Wednesday’s ribbon cutting, Elanco CEO Jeff Simmons said the new, three-building campus and developing OneHealth Innovation District “will write the history for the next 70 years of Elanco.”

Drugmakers buoyed as Trump deal eases worst fears on pricing

October 1, 2025 | Bloomberg News

Shares in Indianapolis-based Eli Lilly and Co. were on the rise Wednesday after President Trump suggested the company would be next up to cut a deal over drug pricing.

Trump to announce drug-pricing deal with Pfizer, new ‘TrumpRx’ website

September 30, 2025 | The Washington Post and IBJ Staff

The announcements are part of an effort to secure “Most Favored Nation” pricing deals with pharmaceutical manufacturers, an effort to link U.S. drug prices to the lowest cost of drugs paid by the wealthiest countries.

What new tariffs mean for pharmaceuticals, patented drugs

September 28, 2025 | The Washington Post

President Donald Trump’s announcement that his administration will impose a 100 percent tariff on patented pharmaceutical products sparked confusion Friday, as government officials, drug companies and trade groups sought clarity on how the levy would be applied.

Trump to put import taxes on pharmaceuticals, kitchen cabinets, furniture and heavy trucks

September 25, 2025 | Associated Press

Trump said on Truth Social that the pharmaceutical tariffs would not apply to companies that are building manufacturing plants in the United States, which he defined as either “breaking ground” or being “under construction.”

IU group among finalists for up to $160M to develop musculoskeletal health hub

September 23, 2025 | IBJ Staff

The goal of the National Science Foundation’s Engines program is to grow regional innovation ecosystems.

Eli Lilly plans to make highly anticipated weight-loss pill at new $6.5B Texas plant

September 23, 2025 | Daniel Lee

The $6.5 billion Houston-area plant is part of the drugmaker’s commitment to add four U.S. manufacturing sites through a $27 billion reshoring investment unveiled early this year.

Pfizer amps up push into obesity treatments with $4.9B deal for Metsera

September 22, 2025 | Associated Press

Demand for obesity treatments has soared recently, due to unprecedented weight loss provided by regular injections of market leaders Wegovy from Novo Nordisk and Zepbound from Indianapolis-based Eli Lilly and Co.

Weight-loss drugs can cut future health costs. The fight is over who pays now.

September 22, 2025 | The Washington Post

Evidence from clinical trials shows that GLP-1s have benefits beyond weight loss, preventing related chronic conditions and ultimately blunting health-plan costs. But the savings might take decades, experts say.

Lilly brain health campaign aims to ward off dementia

September 19, 2025 | Daniel Lee

Eli Lilly and Co. this month launched a public awareness campaign called Brain Health Matters, which features actress Julianne Moore urging people to be proactive as they age to lower their risk of dementia, including Alzheimer’s disease.

Cecil Bohanon and John Horowitz: Owsley showed how art of altruism benefits all

September 19, 2025 | Cecil Bohanon and John Horowitz

The beneficence of the Ball family has long blessed Muncie.

Potential breakup of Corteva plants kernel of uncertainty

September 19, 2025 | Daniel Lee

Ag giant Corteva Agriscience is reportedly mulling a split of its seed and pesticide businesses, a move that could alter the company’s presence in Indianapolis as well as the state’s agriculture industry.

How Indy-area businesses use AI to train employees

September 19, 2025 | Sam Stall

The Carmel-based company, Murray Mentor, has created a voice-in-the-ear AI program that allows novice factory employees to tap the expertise of some of the most-seasoned employees—even if those employees retired long ago.

Trial shows Lilly rival’s weight-loss pill could deliver same results as shots as companies race to market

September 18, 2025 | The Washington Post

Ahead of decisions by the FDA, both Novo Nordisk and Eli Lilly are readying production for their weight-loss pills, having been unable to keep up with demand for their shots that exploded in popularity.

Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

September 17, 2025 | Bloomberg News

Eli Lilly and Co. and Novo Nordisk have been locked in a fierce battle to control the obesity market, which is projected to reach $100 billion by the end of the decade.

« Previous 1 … 7 8 9 10 11 12 Next »

Search Results

237 results for '\"eli lilly\"'